by Devices and Pharma | Apr 2, 2024 | Alerts, FDA Safety Communication, Med-Devices, Product Safety
Update on Plastic Syringe Safety FDA's Ongoing Evaluation and Recommendations Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Today, the U.S. Food and Drug...
by Devices and Pharma | Apr 2, 2024 | Alerts, Alerts-Device, Consumer Safety, FDA Safety Communication, Med-Devices, Product Safety, US-FDA
FDA Warns of Potential Issues with China-made Syringes Quality issues include leaks and breakage Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In an announcement...
by Devices and Pharma | Apr 2, 2024 | Alerts, Alerts-Pharma, Consumer Information, Pharmaceuticals, Product Recalls
AvKARE Recalls Atovaquone Oral Suspension Potential Bacillus cereus contamination discovered during product testing Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact...
by Devices and Pharma | Mar 31, 2024 | Alerts-Pharma, Consumer Safety, FDA Public Information, FDA Safety Communication, Industry News, Product Safety, US-FDA
FDA Warns of Risks with OTC Pain Relief Products High lidocaine concentrations, other issues Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug...
by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...
